V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330011599 | 330012442 | null | 90 | Palliative (P) | 2017-05-15 | 2017-05-16 | EURAMOS TRIAL | 02 | N | 330012860 | EURAMOS TRIAL |
| 330011600 | 330008540 | 1.57 | 67.1 | Curative (C) | null | 2017-03-24 | BENDAMUSTINE + RITUXIMAB | 2 | N | 330012926 | BENDAMUSTINE + RITUXIMAB |
| 330011601 | 330004670 | 0 | null | Curative (C) | 2015-10-17 | 2015-10-18 | Cisplatin + Docetaxel +Fluorouracil | 1 | N | 330012935 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330011603 | 330010632 | 1.79 | 65.3 | Disease modification (D) | 2016-10-25 | 2016-10-25 | Bendamustine+Rituximab(Sub Courses) | N | N | 330012973 | BENDAMUSTINE + RITUXIMAB |
| 330011604 | 330004674 | null | 91.8 | Curative (C) | 2017-04-19 | 2017-04-24 | EURAMOS TRIAL | N | N | 330012974 | EURAMOS TRIAL |
| 330011605 | 330011795 | 1.76 | 97.7 | Curative (C) | 2017-09-09 | 2017-09-09 | Carboplatin+Fluorouracil 4 or 5 day | N | N | 330012994 | CARBO + FLUOROURACIL |
| 330011606 | 330004680 | 1.78 | 103.5 | Palliative (P) | 2017-05-28 | 2017-06-03 | Carboplatin + Paclitaxel (3 weekly) | 01 | N | 330013003 | CARBOPLATIN + PACLITAXEL |
| 330011607 | 330008552 | null | null | Neo-adjuvant (N) | 2014-03-29 | 2014-04-19 | CARBOPLATIN + PACLITAXEL | 99 | Y | 330013004 | CARBOPLATIN + PACLITAXEL |
| 330011608 | 330004683 | 1.69 | 63 | Palliative (P) | 2018-09-08 | 2018-09-20 | Carboplatin + Etoposide IV 3 day | N | N | 330013032 | CARBOPLATIN + ETOPOSIDE |
| 330011609 | 330004684 | 1.72 | 58.1 | Not known (9) | 2018-06-04 | 2018-06-23 | Carboplatin + Etoposide iv&po | N | N | 330013060 | CARBOPLATIN + ETOPOSIDE |
| 330011610 | 330008556 | 1.76 | 78.6 | null | 2017-08-05 | 2017-08-05 | VAI (Ifos 3g/m2) | 2 | N | 330013066 | VAI |
| 330011611 | 330004689 | 1.69 | 96.5 | Palliative (P) | 2016-11-05 | 2017-02-11 | Carboplatin + Etoposide IV 3 day | N | N | 330013074 | CARBOPLATIN + ETOPOSIDE |
| 330011612 | 330004693 | 0 | 99.6 | Curative (C) | 2017-03-26 | 2017-04-30 | CARBOPLATIN + RT | N | N | 330013092 | CARBOPLATIN + RT |
| 330011613 | 330004704 | 1.64 | null | Palliative (P) | 2016-06-21 | 2016-06-21 | ALL UKALL2011 Del Int C Reind PAsp | 02 | N | 330013123 | UKALL2011 |
| 330011614 | 330010643 | 1.75 | 75.099 | Palliative (P) | 2014-05-26 | 2014-06-17 | Carboplatin+Fluorouracil 4 or 5 day | 2 | N | 330013135 | CARBO + FLUOROURACIL |
| 330011615 | 330013175 | 1.48 | null | Palliative (P) | 2015-10-26 | 2016-05-06 | CARBOPLATIN + PACLITAXEL | N | N | 330013139 | CARBOPLATIN + PACLITAXEL |
| 330011616 | 330008567 | 1.73 | null | Palliative (P) | 2015-09-12 | 2015-09-12 | EURAMOS TRIAL | null | N | 330013142 | EURAMOS TRIAL |
| 330011617 | 330004713 | 1.6 | null | Disease modification (D) | 2015-04-27 | 2015-05-30 | Paclitaxel (2 or 3 weekly) | 2 | Y | 330013155 | PACLITAXEL |
| 330011618 | 330010647 | null | 63.2 | Curative (C) | 2016-02-13 | 2016-02-13 | CARBOPLATIN + RT | null | null | 330013182 | CARBOPLATIN + RT |
| 330011619 | 330004724 | 1.72 | 60.9 | Curative (C) | 2014-11-07 | 2015-04-14 | Paclitaxel (2 or 3 weekly) | 02 | N | 330013187 | PACLITAXEL |
| 330011620 | 330013054 | 1.62 | 88.6 | Palliative (P) | 2015-10-28 | 2015-11-01 | ALL UKALL2011 Aug BFM Cons C PegAsp | 02 | N | 330013194 | UKALL2011 |
| 330011621 | 330004731 | 1.69 | 89 | Curative (C) | 2015-07-11 | 2015-07-17 | ALL UKALL2011 Maintenance A3 | 02 | N | 330013234 | UKALL2011 |
| 330011622 | 330004735 | null | 76.9 | Curative (C) | null | 2018-02-04 | ALL UKALL2011 Maintenance B3 | N | null | 330013247 | UKALL2011 |
| 330011623 | 330004742 | null | 86.7 | Curative (C) | 2013-05-22 | 2013-05-25 | ALL UKALL2011 Aug BFM Cons C PegAsp | null | null | 330013250 | UKALL2011 |
| 330011624 | 330004751 | 1.63 | 22.3 | Disease modification (D) | 2016-07-21 | 2016-08-26 | Carboplatin + Paclitaxel (3 weekly) | N | null | 330013281 | CARBOPLATIN + PACLITAXEL |
| 330011625 | 330010655 | 1.63 | 41.9 | Disease modification (D) | 2017-01-09 | 2017-04-16 | VAI (Ifos 3g/m2) | 02 | N | 330013303 | VAI |
| 330011626 | 330008589 | 1.69 | 58 | Neo-adjuvant (N) | 2013-10-05 | 2014-06-28 | EURAMOS TRIAL | N | N | 330013306 | EURAMOS TRIAL |
| 330011627 | 330004760 | 1.74 | 101.6 | Curative (C) | null | 2017-06-08 | Cetuximab + Radiotherapy Maint | N | N | 330013308 | CETUXIMAB + RT |
| 330011628 | 330004764 | 0 | 19.7 | Palliative (P) | 2016-12-31 | 2017-07-24 | Carboplatin+Fluorouracil 4 or 5 day | N | N | 330013311 | CARBO + FLUOROURACIL |
| 330011629 | 330004771 | 1.57 | 10.6 | Palliative (P) | 2016-05-21 | 2016-07-10 | Carboplatin + Paclitaxel (3 weekly) | N | N | 330013323 | CARBOPLATIN + PACLITAXEL |
| 330011630 | 330010659 | 1.43 | 96.5 | Adjuvant (A) | 2017-03-11 | 2017-04-04 | VAI (Ifos 3g/m2) | N | N | 330013345 | VAI |
| 330011631 | 330004778 | 1.78 | 88 | Palliative (P) | 2017-09-06 | 2017-09-06 | EURAMOS TRIAL | N | Y | 330013489 | EURAMOS TRIAL |
| 330011632 | 330004781 | 1.72 | null | Curative (C) | 2014-07-31 | 2014-07-31 | CARBOPLATIN + RT | N | N | 330013513 | CARBOPLATIN + RT |
| 330011633 | 330004782 | 1.56 | 72.9 | Palliative (P) | 2017-12-13 | 2018-06-21 | Cisplatin + Docetaxel +Fluorouracil | Y | N | 330013532 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330011634 | 330008609 | null | 61.6 | Palliative (P) | null | 2016-02-06 | Carboplatin+Fluorouracil 4 or 5 day | 2 | null | 330013620 | CARBO + FLUOROURACIL |
| 330011636 | 330004795 | 1.69 | 108.2 | Curative (C) | 2014-10-08 | 2014-10-08 | CETUXIMAB + RT | N | null | 330013711 | CETUXIMAB + RT |
| 330011638 | 330011814 | 1.72 | 95 | Adjuvant (A) | 2017-07-30 | 2017-07-31 | VAI (Ifos 3g/m2) | N | N | 330013738 | VAI |
| 330011639 | 330011814 | 0 | 112 | Curative (C) | 2016-10-08 | 2016-11-26 | EURAMOS TRIAL | Y | N | 330013738 | EURAMOS TRIAL |
| 330011640 | 330004801 | 1.7 | 70.6 | Palliative (P) | 2018-07-14 | 2018-08-22 | Carboplatin + Etoposide IV 3 day | N | N | 330013757 | CARBOPLATIN + ETOPOSIDE |
| 330011642 | 330004811 | 1.73 | 75.4 | Palliative (P) | 2016-05-22 | 2016-07-24 | BENDAMUSTINE + RITUXIMAB | 02 | N | 330013895 | BENDAMUSTINE + RITUXIMAB |
| 330011643 | 330004813 | 1.57 | 84.55 | Curative (C) | 2017-11-14 | 2018-02-11 | CARBOPLATIN + ETOPOSIDE | 02 | N | 330013921 | CARBOPLATIN + ETOPOSIDE |
| 330011644 | 330004816 | 0 | 46.3 | Not known (9) | 2017-10-21 | 2017-10-23 | BENDAMUSTINE + RITUXIMAB | Y | N | 330013930 | BENDAMUSTINE + RITUXIMAB |
| 330011645 | 330004819 | 1.71 | 45.9 | Palliative (P) | 2016-11-14 | 2016-11-30 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | N | 330013942 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330011646 | 330008632 | null | 73.75 | Curative (C) | 2018-01-09 | 2018-01-15 | CARBOPLATIN + RT | null | Y | 330013969 | CARBOPLATIN + RT |
| 330011647 | 330004826 | 1.67 | 76 | Palliative (P) | null | 2013-09-05 | Paclitaxel 80mg/m2 day 1 8 15 | Y | null | 330013979 | PACLITAXEL |
| 330011649 | 330004832 | 1.73 | 78.8 | Curative (C) | 2015-03-29 | 2015-04-26 | CARBOPLATIN + ETOPOSIDE | N | N | 330014044 | CARBOPLATIN + ETOPOSIDE |
| 330011650 | 330004838 | 1.58 | 64 | Palliative (P) | 2013-04-29 | 2013-05-02 | ALL UKALL2011 Ind A Std Dex (PAsp) | 02 | N | 330014135 | UKALL2011 |
| 330011651 | 330010685 | 1.67 | 63.8 | Palliative (P) | 2014-07-06 | 2014-07-06 | TEMOZOLOMIDE | null | null | 330014152 | NIVOLUMAB |
| 330011652 | 330013253 | 1.55 | 102 | Disease modification (D) | 2016-01-28 | 2016-02-03 | CISPLATIN + ETOPOSIDE | 02 | N | 330014163 | CISPLATIN + DOXORUBICIN |
| 330011653 | 330010687 | 1.58 | 122.4 | Curative (C) | 2017-07-01 | 2017-07-02 | VAC | N | N | 330014219 | CYCLOPHOSPHAMIDE + TOPOTECAN |